Invokana and Amputation Risk: E.U. Health Authorities Now Require Package Warning

by KJ McElrath | Mar 2, 2017 | Invokana |

Last year (May 2016), the U.S. Food and Drug Administration issued an “advisory” to physicians...

Despite Proven Side Effects and Lawsuits, Johnson & Johnson and Janssen Pharmaceuticals Continue Looking to Expand Market for Invokana

by KJ McElrath | Jan 6, 2017 | Invokana |

The diabetes “wonder drug,” Invokana (canagliflozin), has been demonstrated to cause a dangerous...

Invokana and Other SGLT2 Inhibitors Linked to Acute Pancreatitis

by KJ McElrath | Dec 13, 2016 | Invokana |

In addition to ketoacidosis (dangerous acidity levels in the blood), kidney damage and a host of...

Yes, Invokana Helps Weight Loss – But Only For Awhile

by KJ McElrath | Oct 20, 2016 | Invokana |

One of the selling points of the prescription diabetes medication Invokana (canagliflozin) has...

How Fast Acting is Invokana? Ask Some of the Plaintiffs Who Were Quickly Injured by the Drug

by KJ McElrath | Sep 14, 2016 | Invokana |

Unlike many popular medications prescribed for a wide range of ailments, Invokana is not...

Invokana as a Weight Loss Aid? Is This A Good Idea?

by KJ McElrath | Sep 10, 2016 | Invokana |

In 2015, Johnson & Johnson’s revenue fell by nearly 6%. However, sales of Invokana...